Tongtong An

3.3k total citations
90 papers, 1.6k citations indexed

About

Tongtong An is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Tongtong An has authored 90 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Pulmonary and Respiratory Medicine, 62 papers in Oncology and 18 papers in Molecular Biology. Recurrent topics in Tongtong An's work include Lung Cancer Treatments and Mutations (59 papers), Lung Cancer Research Studies (32 papers) and Colorectal Cancer Treatments and Studies (21 papers). Tongtong An is often cited by papers focused on Lung Cancer Treatments and Mutations (59 papers), Lung Cancer Research Studies (32 papers) and Colorectal Cancer Treatments and Studies (21 papers). Tongtong An collaborates with scholars based in China, Ethiopia and United States. Tongtong An's co-authors include Minglei Zhuo, Meina Wu, Hua Bai, Jianchun Duan, Zhijie Wang, Jun Zhao, Jie Wang, Yuyan Wang, Shuhang Wang and Lu Yang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Tongtong An

88 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tongtong An China 23 1.1k 912 620 527 128 90 1.6k
Minglei Zhuo China 22 996 0.9× 833 0.9× 607 1.0× 501 1.0× 150 1.2× 99 1.6k
Xian Lu United States 20 1.3k 1.3× 1.1k 1.2× 454 0.7× 642 1.2× 131 1.0× 39 1.9k
Jianchun Duan China 23 1.1k 1.0× 1.0k 1.1× 673 1.1× 511 1.0× 139 1.1× 96 1.7k
Felice Mucilli Italy 16 1.5k 1.4× 1.1k 1.2× 464 0.7× 756 1.4× 139 1.1× 59 2.0k
Rintaro Noro Japan 25 811 0.8× 697 0.8× 531 0.9× 978 1.9× 92 0.7× 95 1.8k
Chiara Lazzari Italy 24 738 0.7× 883 1.0× 313 0.5× 580 1.1× 103 0.8× 67 1.5k
Ana Giménez‐Capitán Spain 22 879 0.8× 930 1.0× 592 1.0× 954 1.8× 167 1.3× 77 1.9k
Soji Kakiuchi Japan 21 910 0.9× 850 0.9× 313 0.5× 998 1.9× 116 0.9× 41 1.9k
Monica Ganzinelli Italy 23 908 0.9× 1.2k 1.3× 309 0.5× 710 1.3× 112 0.9× 83 1.9k
Marta Castiglia Italy 22 518 0.5× 619 0.7× 608 1.0× 730 1.4× 134 1.0× 52 1.5k

Countries citing papers authored by Tongtong An

Since Specialization
Citations

This map shows the geographic impact of Tongtong An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tongtong An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tongtong An more than expected).

Fields of papers citing papers by Tongtong An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tongtong An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tongtong An. The network helps show where Tongtong An may publish in the future.

Co-authorship network of co-authors of Tongtong An

This figure shows the co-authorship network connecting the top 25 collaborators of Tongtong An. A scholar is included among the top collaborators of Tongtong An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tongtong An. Tongtong An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kong, Ling‐Dong, Minglei Zhuo, Tongtong An, et al.. (2024). Women patients with small‐cell lung cancer using immunotherapy in a real‐world cohort achieved long‐term survival. Thoracic Cancer. 15(23). 1727–1738. 1 indexed citations
2.
Li, Junfeng, Huifeng Hao, Jia Wang, et al.. (2023). Secreted proteins MDK, WFDC2, and CXCL14 as candidate biomarkers for early diagnosis of lung adenocarcinoma. BMC Cancer. 23(1). 110–110. 11 indexed citations
3.
Wang, Yuyan, Qiwen Zheng, Bo Jia, et al.. (2020). Effects of Surgery on Survival of Early-Stage Patients With SCLC: Propensity Score Analysis and Nomogram Construction in SEER Database. Frontiers in Oncology. 10. 626–626. 19 indexed citations
4.
Zhuo, Minglei, Tongtong An, Chaoting Zhang, & Ziping Wang. (2020). Characterization of Microbiota in Cancerous Lung and the Contralateral Non-Cancerous Lung Within Lung Cancer Patients. Frontiers in Oncology. 10. 1584–1584. 21 indexed citations
5.
Wang, Lu, Jun Zhao, Tongtong An, et al.. (2020). Clinical Characteristics and Outcomes of Patients With Primary Mediastinal Germ Cell Tumors: A Single-Center Experience. Frontiers in Oncology. 10. 1137–1137. 7 indexed citations
6.
Zhou, Qing, Lin Wu, Feng Luo, et al.. (2019). Safety and efficacy of abivertinib (AC0010), a third-generation EGFR tyrosine kinase inhibitor, in Chinese patients with EGFR-T790M positive non-small cell lung cancer (NCSLC).. Journal of Clinical Oncology. 37(15_suppl). 9091–9091. 5 indexed citations
7.
Yu, Jiangyong, Shuhang Wang, Wei Zhao, et al.. (2018). Mechanistic Exploration of Cancer Stem Cell Marker Voltage-Dependent Calcium Channel α2δ1 Subunit-mediated Chemotherapy Resistance in Small-Cell Lung Cancer. Clinical Cancer Research. 24(9). 2148–2158. 47 indexed citations
8.
Zhuo, Minglei, Hanxiao Chen, Tianzhuo Zhang, et al.. (2018). The potential predictive value of circulating immune cell ratio and tumor marker in atezolizumab treated advanced non-small cell lung cancer patients. Cancer Biomarkers. 22(3). 467–476. 31 indexed citations
9.
Wan, Rui, Zhijie Wang, J. Jack Lee, et al.. (2017). Comprehensive Analysis of the Discordance of EGFR Mutation Status between Tumor Tissues and Matched Circulating Tumor DNA in Advanced Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 12(9). 1376–1387. 34 indexed citations
10.
11.
Wang, Yuyan, Li Liu, Jia Zhong, et al.. (2015). [Prognostic factors and response of chemotherapy including amrubicin in small cell lung cancer patients].. PubMed. 38(4). 261–6. 1 indexed citations
12.
Zhuo, Minglei, Hua Bai, Zhijie Wang, et al.. (2014). Rechallenge with pemetrexed-based chemotherapy improves the survival of patients with advanced non-squamous non-small-cell lung cancer. Molecular and Clinical Oncology. 2(6). 953–959. 8 indexed citations
13.
Wang, Zhijie, Rui Chen, Shuhang Wang, et al.. (2014). Quantification and Dynamic Monitoring of EGFR T790M in Plasma Cell-Free DNA by Digital PCR for Prognosis of EGFR-TKI Treatment in Advanced NSCLC. PLoS ONE. 9(11). e110780–e110780. 112 indexed citations
14.
Bai, Hua, Zhijie Wang, Yuyan Wang, et al.. (2013). Detection and Clinical Significance of Intratumoral EGFR Mutational Heterogeneity in Chinese Patients with Advanced Non-Small Cell Lung Cancer. PLoS ONE. 8(2). e54170–e54170. 83 indexed citations
15.
Huang, Zhen, Zhijie Wang, Hua Bai, et al.. (2012). The detection of EGFR mutation status in plasma is reproducible and can dynamically predict the efficacy of EGFR‐TKI. Thoracic Cancer. 3(4). 334–340. 36 indexed citations
16.
Wang, Shuhang, Tongtong An, Jie Wang, et al.. (2010). Potential Clinical Significance of a Plasma-Based KRAS Mutation Analysis in Patients with Advanced Non–Small Cell Lung Cancer. Clinical Cancer Research. 16(4). 1324–1330. 83 indexed citations
17.
Wang, Zhijie, Jianchun Duan, Qingzhi Guo, et al.. (2008). [A phase II clinical trial of celecoxib combined with platinum-based chemotherapy in the treatment of patients with advanced NSCLC as first-line treatment.].. SHILAP Revista de lepidopterología. 11(3). 425–30. 6 indexed citations
18.
Bai, Hua, Jun Zhao, Shuhang Wang, et al.. (2008). [The detection by denaturing high performance liquid chromatography of epidermal growth factor receptor mutation in tissue and peripheral blood from patients with advanced non-small cell lung cancer].. PubMed. 31(12). 891–6. 4 indexed citations
19.
An, Tongtong, et al.. (2004). [Primary assessment of treatment effect of thymosin alpha1 on chemotherapy-induced neurotoxicity].. PubMed. 23(11 Suppl). 1428–30. 8 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Minglei Zhuo Breakdown of academic impact, for papers by Xian Lu Breakdown of academic impact, for papers by Jianchun Duan Breakdown of academic impact, for papers by Felice Mucilli Breakdown of academic impact, for papers by Rintaro Noro Breakdown of academic impact, for papers by Chiara Lazzari Breakdown of academic impact, for papers by Ana Giménez‐Capitán Breakdown of academic impact, for papers by Soji Kakiuchi Breakdown of academic impact, for papers by Monica Ganzinelli Breakdown of academic impact, for papers by Marta Castiglia
Rankless by CCL
2026